Early immunologic and virologic responses to highly active antiretroviral therapy and subsequent disease progression among HIV-infected injection drug users.
about
Drug-drug interactions between anti-retroviral therapies and drugs of abuse in HIV systemsHIV among persons incarcerated in the USA: a review of evolving concepts in testing, treatment, and linkage to community careIncreases in CD4+ T-cell count at antiretroviral therapy initiation among HIV-positive illicit drug users during a treatment-as-prevention initiative in Canada.Alcohol consumption effect on antiretroviral therapy and HIV-1 pathogenesis: role of cytochrome P450 isozymes.Temporal trends in highly active antiretroviral therapy initiation among injection drug users in Baltimore, Maryland, 1996-2008Factors associated with paradoxical immune response to antiretroviral therapy in HIV infected patients: a case control study.Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression.Immunological failure despite virological suppression in HIV seropositive individuals on antiretroviral therapy.Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy.Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: a survey of North American HIV providers.The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis.Discordance between CD4+ T-lymphocyte counts and percentages in HIV-infected persons with liver fibrosisU.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008.Changes in sexual and drug-related risk behavior following antiretroviral therapy initiation among HIV-infected injection drug users.Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users.HIV Treatment for Alcohol and Non-Injection Drug Users in El Salvador.Nonstructured treatment interruptions among injection drug users in Baltimore, MD.Social and structural factors associated with HIV disease progression among illicit drug users: a systematic reviewSubstance use: impact on adherence and HIV medical treatment.Effect of hepatitis C virus on immunological and virological responses in HIV-infected patients initiating highly active antiretroviral therapy: a meta-analysis.
P2860
Q26851241-163116AD-E524-4DBD-AE24-77A40963E8D4Q27014885-11865A97-429C-49E8-AB2F-8348FF918AA1Q30399058-16A9C53C-6FEE-434C-8D6A-5944B4E5B32DQ33660210-AB91F502-8EE6-414E-9F8D-6A968E23F906Q33867166-1C10757D-E477-4AF1-A66D-6CFD7C1DE8FDQ34065045-46BC8DA6-423C-4111-BC9D-310CBBB7C5F5Q34546011-1A9F9B8F-0A68-4867-BF58-70F4276867E9Q35366136-AE3210AE-7D79-4B9E-B2E2-771AE77B4908Q35452380-DF61D4FA-70B2-475B-80ED-79B8B02C0517Q35835854-7F86AE60-698D-4217-9225-92F0C12B3C83Q35962516-EEE8C0A5-DC0D-41FC-A266-E378B73CE118Q36115602-78A89E50-59BE-4CFA-8D7C-4F759ADEEF39Q36501102-97390E49-E2F2-4DE3-AB43-6E5F7E596E47Q36919650-D280889E-A37D-47D6-9DCA-246531289B5DQ37227942-C90047F0-37A1-4578-82A0-2EFF30C93548Q37265329-46CA2E17-3C08-491B-9015-5E11223E8A27Q37434895-BD293B81-571F-4C2B-8C36-F1C2699E6ACAQ37638817-039815A3-F599-462B-ACE3-4E125E2B569EQ37920746-E7FBC894-20FE-49DC-B194-7EBEBE8C6298Q42271731-57918553-A4CC-43EB-829F-75746647929C
P2860
Early immunologic and virologic responses to highly active antiretroviral therapy and subsequent disease progression among HIV-infected injection drug users.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Early immunologic and virologi ...... infected injection drug users.
@en
Early immunologic and virologi ...... infected injection drug users.
@nl
type
label
Early immunologic and virologi ...... infected injection drug users.
@en
Early immunologic and virologi ...... infected injection drug users.
@nl
prefLabel
Early immunologic and virologi ...... infected injection drug users.
@en
Early immunologic and virologi ...... infected injection drug users.
@nl
P2093
P2860
P1433
P1476
Early immunologic and virologi ...... infected injection drug users.
@en
P2093
P2860
P304
P356
10.1080/09540120701235644
P577
2007-05-01T00:00:00Z